Physician
Urology
Dr. Dipen J. Parekh, MD
|
|
Give Review
Dipen Parekh practices Urology. He over the years received 4 awards: "GOLD CYSTOSCOPE AWARD", "America's Top Doctors", "America's Top Doctors for Cancer" and "CMS Meaningful Use Stage 1 Certification". Dipen Parekh is a published doctor as well. He has 73 publications published. The latest was: Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- The RAZOR (randomized open vs robotic Cystectomy) trial: study design and trial update.
- A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer.
- Health Related Quality of Life From A Prospective Randomized Clinical Trial of Robotic Assisted Laparoscopic Versus Open Radical Cystectomy.
- Current status of robotic and laparoscopic techniques in radical cystectomy and diversion procedures for Bladder cancer: review.
- Prevention and treatment of biopsy-related complications.
- Definition, incidence, risk factors, and prevention of paralytic ileus following radical Cystectomy: a systematic review.
- Rise of robotics in Urologic surgery: current status and future directions.
- Tolerance of the human Kidney to isolated controlled ischemia.
- Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical Cystectomy.
- Stabilization of HIF-2α through redox regulation of mTORC2 activation and initiation of mRNA translation.
- microRNA-21 Governs TORC1 Activation in Renal Cancer Cell Proliferation and Invasion.
- Evaluating the Prostate Cancer Prevention Trial High Grade prostate Cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collabo...
- Warming Up to Ischemia.
- Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
- Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborativ...
- Active surveillance: pitfalls to consider.
- The rapid uptake of robotic Prostatectomy and its collateral effects.
- Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2? Accumulation and Promotes Migration and Invasion.
- The relationship between prostate-specific antigen and prostate Cancer risk: the Prostate Biopsy Collaborative Group.
- The NADPH oxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin.
- Active surveillance for favorable risk prostate Cancer. Beware the risks.
- Yearly Prostate specific antigen and digital rectal examination fluctuations in a screened population.
- The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate Cancer.
- Surgical management of von Hippel-Lindau Disease: urologic considerations.
- Total Prostate specific antigen stability confirmed after long-term storage of serum at -80C.
- Commentary on early hormonal therapy for PSA only recurrence after radical Prostatectomy--success towards survival or antidote to anxiety?
- Biomarkers for prostate Cancer detection.
- Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate Cancer.
- Prostate Cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
- Assessment of 54 biomarkers for biopsy-detectable prostate Cancer.
- Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate Cancer prognosis: a tocsin calling for prospective studies.
- Urinary diversion: options, patient selection, and outcomes.
- Superficial and muscle-invasive Bladder cancer: principles of management for outcomes assessments.
- External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population.
- In vivo assessment of radio frequency induced thermal damage of Kidney using optical spectroscopy.
- Optical spectroscopy characteristics can differentiate benign and malignant Renal tissues: a potentially useful modality.
- Renal cell carcinoma with Renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
- UreteroneoCystostomy without urethral catheterization shortens hospital stay without compromising postoperative success.
- Simplified laparoscopic radical cystectomy with orthotopic ileal neoBladder creation in a porcine model.
- Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk.
- Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate Cancer.
- Complications of radical cystectomy for nonmuscle invasive Disease: comparison with muscle invasive Disease.
- Primary neuroendocrine carcinoma of the urethra.
- Orthotopic neoBladder following radical cystectomy in patients with high perioperative risk and co-morbid medical conditions.
- Leiomyosarcoma in urinary Bladder after cyclophosphamide therapy for retinoblastoma and review of Bladder sarcomas.
- Outcome of sibling vesicoUreteral reflux.
- The association of an increased urinary calcium-to-creatinine ratio, and asymptomatic gross and microscopic Hematuria in children.
- Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive Bladder cancer.
- Methods to predict and lower the risk of prostate Cancer.
- Prostate Cancer: treatment triggers for patients on active surveillance.
- Prostate Cancer prevention with 5 alpha-reductase inhibitors.
- Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis.
- Words of wisdom. Re: Trends in pelvic lymphadenectomy at the time of radical Cystectomy: 1988 to 2004. Hellenthal NJ, Ramirez ML, Evans CP, deVere White RW, Koppie TM.
- Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the Bladder.
- Health related quality of life assessment after radical Prostatectomy in men with Prostate specific antigen only recurrence.
- Predicting prostate Cancer risk through incorporation of prostate Cancer gene 3.
- Functional lower urinary tract voiding outcomes after cystectomy and orthotopic neoBladder.
- The role of hypercalciuria in a subgroup of Dysfunctional voiding syndromes of childhood.
- The use of radiography, urodynamic studies and cystoscopy in the evaluation of voiding Dysfunction.
- Continent Urinary reconstruction versus ileal conduit: a contemporary single-institution comparison of perioperative morbidity and mortality.
- Characterization and predictors of Prostate specific antigen progression rates after radical retropubic Prostatectomy.
- Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature.
- Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
- Assessment of resectability of pancreatic head and periampullary tumors by color flow Doppler sonography.
- Factors influencing the morbidity of colostomy closure.
- Post-traumatic parotid fistulae and sialoceles. A prospective study of conservative management in 51 cases.
- Management of duodenal perforation after endoscopic retrograde cholangiopancreatography and sphincterotomy.
- Does an infected peripancreatic fluid collection or abscess mandate operation?
- Laparoscopic choleCystectomy: laboratory predictors of choledocholithiasis.
- The effect of Chronic acidification of the canine duodenum on gastrin release from the antrum transplanted into the colon.
- Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active Surveillance.
- The 4Kscore® Test Reduces Prostate Biopsy Rates in Community and Academic Urology Practices.
Procedures Preformed
- AdRenalectomy
- Advanced Robotic Surgery
- Bladder Repair Surgery
- Bladder Surgery
- View All
Conditions Treated
- Bladder Cancer
- Bladder Stones
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- GOLD CYSTOSCOPE AWARD
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
Education
-
Memorial Sloan-Kettering Cancer Center -
Vanderbilt University
Hospital
-
University of Miami Hospital
Drug Facts
| NPI NUMBER | 1699715029 | |
| NPPES Provider LastName | PAREKH | |
| NPPES Provider FirstName | DIPEN | |
| NPPES Provider ZIPCode | 331361005 | |
| NPPES Provider State | FL | |
| Specialty Description | Urology | |
| Total Claim Count | 89.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699715029 |
| Last Name Of The Provider | PAREKH |
| First Name Of The Provider | DIPEN |
| View All |
Similar Doctors
|
Dr. James D. Daughtry, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cesar J. Sastre, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Miguel Suarez, MD |
|
|
Dr. Carlos A. Nazir, MD |
|
|
Dr. David G. Alonzo, MD |
|
|
Dr. Peter A. Mennie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher Gomez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Devendar Katkoori, MD |
|
|
Dr. Emiliano H. Morillo, MD |
|
|
Dr. Kishore Thekke Adiyat, MD |